Does Rallies show 13F holders for FBLG?

Yes. Rallies tracks hedge fund and 13F ownership data for FBLG, including fund names, share counts, latest tracked quarter, and position changes when available.

Is FBLG research on Rallies investment advice?

No. Rallies provides research, data, and educational context for FBLG. It does not provide personalized investment advice.

FBLG (FibroBiologics, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

FibroBiologics, Inc. Common Stock (FBLG) is a publicly traded Healthcare sector company. As of May 21, 2026, FBLG trades at $1.06 with a market cap of $5.68M and a P/E ratio of -2.45. FBLG moved -4.17% today. Year to date, FBLG is -78.44%; over the trailing twelve months it is -94.25%. Its 52-week range spans $0.95 to $77.80. Analyst consensus is buy with an average price target of $8.00. Rallies surfaces FBLG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns FBLG stock?

Hedge funds tracked by Rallies that own FBLG include Exoduspoint Capital. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for FibroBiologics, Inc. Common Stock.

FBLG Key Metrics

Key financial metrics for FBLG
Metric	Value
Price	$1.06
Market Cap	$5.68M
P/E Ratio	-2.45
EPS	$-0.42
Dividend Yield	0.00%
52-Week High	$77.80
52-Week Low	$0.95
Volume	406
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-18.65M
Gross Margin	0.00%

Top Hedge Funds Holding FBLG

Exoduspoint Capital holds 25.59K shares of FBLG, changed +0.00% as of Mar 31, 2024.

Latest FBLG News

FibroBiologics Achieves 3-Fold IL1B Reduction, 4-Fold IL10 Rise in Burn Study — May 4, 2026
FibroBiologics Releases cGMP-Compliant CYWC628 Batch for Diabetic Foot Ulcer Trial — May 4, 2026
FibroBiologics’ Matrix-Free Thymus Organoids Generate Diverse T Cells, Slow Melanoma Growth — Apr 10, 2026
FibroBiologics Raises $3M via 2.27M Share Offering and Warrants — Apr 2, 2026
FibroBiologics Completes First CGMP Batch of CYWC628 for Diabetic Foot Ulcer Trial — Mar 31, 2026

Recent FBLG Insider Trades

Khoja Hamid bought 30.00K (~$11.40K) on Mar 4, 2026.
O'HEERON PETE bought 15.87K (~$6.01K) on Mar 4, 2026.
O'HEERON PETE bought 18.20K (~$7.37K) on Mar 3, 2026.

FBLG Analyst Consensus

3 analysts cover FBLG: 0 strong buy, 1 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.00.

Common questions about FBLG

Who owns FBLG stock?: Hedge funds tracked by Rallies that own FBLG include Exoduspoint Capital. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for FibroBiologics, Inc. Common Stock.
Does Rallies show 13F holders for FBLG?: Yes. Rallies tracks hedge fund and 13F ownership data for FBLG, including fund names, share counts, latest tracked quarter, and position changes when available.
Is FBLG research on Rallies investment advice?: No. Rallies provides research, data, and educational context for FBLG. It does not provide personalized investment advice.